ResearchMoz

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-12-20
No. Of Pages » 105
 Orthobiology is a branch of science that develops bone and tissue replacement materials for skeletal and tissue healing. Orthobiologics has been gaining popularity since it provides accelerated healing, faster recovery and reduction in number of hospital visits. A rise in the incidence of arthritis and geriatric population has triggered the growth of this market. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and rising participation in sports related activities has considerably augmented the growth of this market. 
   
 The research report on orthobiologics provides...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
2.2 Global Orthobiologics Market, by Products, 2012 (USD Million)
2.3 Global Orthobiologics Market, by Applications, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Drivers
3.1.1.1 Rising prevalence of chronic arthritis and rapidly aging world population
3.1.1.2 Surge in sports injuries
3.1.1.3 Surge in the number of orthopedic surgeries
3.1.1.4 Technological advances in bone graft materials to boost market growth
3.1.1.5 Demand for innovative products to bolster the growth of the market
3.1.2 Restraints
3.1.2.1 Lack of Reimbursement
3.1.2.2 Stringent regulatory requirements to restrain market growth
3.1.3 Opportunities
3.1.3.1 Rise in cell based matrices
3.1.3.2 Emerging markets
3.2 Porter’s Five Force Analysis: Global Orthobiologics Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Orthobiologics Market, by Geography

Chapter 4 Global Orthobiologics Market, by Product
4.1 Overview
4.1.1 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
4.2 Bone Morphogenetic Proteins
4.2.1 Global Bone Morphogenetic Proteins Product Market, 2011 – 2019 (USD Million)
4.3 Demineralized Bone Matrix (DBM)
4.3.1 Global Demineralized Bone Matrix Product Market, 2011 – 2019 (USD Million)
4.4 Synthetic Bone Substitutes
4.4.1 Global Synthetic Bone Substitutes Product Market, 2011 – 2019 (USD Million)
4.5 Viscosupplementation
4.5.1 Global Viscosupplementation Product Market, 2011 – 2019 (USD Million)
4.6 Allograft
4.6.1 Global Allografts Product Market, 2011 – 2019 (USD Million)
4.7 Stem Cell Therapy
4.7.1 Global Stem Cell Therapy Product Market, 2011 – 2019 (USD Million)
4.8 Machined Bones
4.8.1 Global Machined Bones Product Market, 2011 – 2019 (USD Million)

Chapter 5 Global Orthobiologics Market, by Application
5.1 Overview
5.1.1 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Spinal Fusion
5.2.1 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
5.3 Trauma
5.3.1 Global Trauma Application Market, 2011 – 2019 (USD Million)
5.4 Reconstructive surgery
5.4.1 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

Chapter 6 Global Orthobiologics Market, by Geography
6.1 Overview
6.1.1 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.3.2 North America Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.4.2 Europe Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia-Pacific Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.6.2 RoW Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

Chapter 7 Global Orthobiologics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Orthobiologics Market
7.1.1 Global Orthobiologics Market Share Analysis, by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Success strategies
8.1.1 Rigorous research and development (R&D) initiatives
8.1.2 Investing in emerging economies
8.2 Barriers to be considered
8.2.1 Significant Cost of Investment

Chapter 9 Company Profiles
9.1 Alphatec Spine, Inc.
9.1.1 Business Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Bacterin International, Inc.
9.2.1 Business Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Biomet, Inc.
9.3.1 Business overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 DePuy Synthes, Inc. (A Johnson & Johnson Company)
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Exactech, Inc.
9.5.1 Business Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Globus Medical, Inc.
9.6.1 Business Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Integra LifeSciences Corporation
9.7.1 Business Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Medtronic, Inc.
9.8.1 Business Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 NuVasive, Inc.
9.9.1 Business Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Orthofix Holdings, Inc.
9.10.1 Business Overview
9.10.2 Financial Overview
9.10.3 Products Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Regeneration Technologies, Inc.
9.11.1 Business Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Sanofi
9.12.1 Business Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Stryker Corporation
9.13.1 Business Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Wright Medical Technology, Inc.
9.14.1 Business Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
9.15 Zimmer Holdings, Inc.
9.15.1 Business Overview
9.15.2 Financial Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.15.5 Recent Developments

List of Tables

TABLE 1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
TABLE 2 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 3 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 5 North America Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 6 North America Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Europe Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 8 Europe Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 9 Asia-Pacific Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 11 RoW Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 12 RoW Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Orthobiologics: Market Segmentation
FIG. 2 Global Orthobiologics Market, by Products, 2012 (USD Million)
FIG. 3 Global Orthobiologics Market, by Application, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Orthobiologics Market
FIG. 5 Market Attractiveness Analysis: Global Orthobiologics Market, by Geography
FIG. 6 Global Bone Morphogenetic Protein Products, 2011 – 2019 (USD Million)
FIG. 7 Global Demineralized Bone Matrix Products, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Bone Substitute Products, 2011 – 2019 (USD Million)
FIG. 9 Global Viscosupplementation Products, 2011 – 2019 (USD Million)
FIG. 10 Global Allograft Products, 2011 – 2019 (USD Million)
FIG. 11 Global Stem Cell Therapy Products, 2011 – 2019 (USD Million)
FIG. 12 Global Machined Bone Products, 2011 – 2019 (USD Million)
FIG. 13 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
FIG. 14 Global Trauma Application Market, 2011 – 2019 (USD Million)
FIG. 15 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)
FIG. 16 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
FIG. 17 Global Orthobiologics: Market Share, by Key Players, 2012 (%)
FIG. 18 Alphatec Spine, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Bacterin International Holdings, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 20 Biomet, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Johnson & Johnson, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Exactech, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Globus Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Integra LifeSciences Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 NuVasive, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)
FIG. 28 Regeneration Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Sanofi, Annual Revenue: 2010 – 2012 (USD Million) (1 Euro= 1.31 USD)
FIG. 30 Stryker Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Wright Medical Technology, Inc.: Annual Revenue 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc, Annual Revenue: 2010 – 2012 (USD Million)

Upcoming Reports:

Wound Closure Devices Market- Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecasts 2010 - 2017
By - Transparency Market Research
Wound closure devices is a relatively new device category, these devices assist in help bring the edges of the open wound closer together and keep them together once they touch. These devices find their applications in surgical operations for the closure of surgical incisions and also for wounds caused accidently. The different types of wound closure devices are sutures, mechanical wound closure devices, wound strips and skin adhesives. Globally, the wound closure market is dominated by sutures followed by mechanical wound closure devices.  The industry is constantly...
Biodegradable Polymers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Polymers which break down, degrade and dispose easily without affecting the environment are called biodegradable plastics. They can be used in medical devices which can be used to operate human bodies and can be left inside the body to degrade. The major driving force behind the growing market of biodegradable polymers is the environmental hazards caused by the usage of non-degradable polymers (petroleum based polymers). People are becoming more aware about the effect that non-renewable polymers are having on the environment. Another factor which is driving the biodegradable...
Crude Oil Carriers Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Crude oil carriers are generally referred to as oil tankers that transport crude oil from one place to another. Oil tankers are designed for the bulk transport of oil. Crude tankers transport unrefined crude oil from extraction location to the refineries. Tanker shipping provides a convenient way of transporting bulk liquid for international seaborne trade. Transportation rates in the shipping industry are determined by time charter equivalent. Oil tankers have become an integral part of the transportation process. Crude oil carriers are typically classified on the basis of Dead...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...
Chinese manufacturing gauge gets a hike after months
Jul 24, 2014  
China manufacturing gauge has climbed to its 18-month high this month, which has boosted the government’s chance of meeting the target for economic growth set for 2014, by a percentage of 7.5. The Purchasing Managers Index (PMI) preliminary from Markit Economics and HSBC Holdings Plc was at 52.0 and its has topped the 51.0 median estimate. These numbers indicate an above 50 mark. The...
Paracetamol doesn’t speed recovery or reduce low back pain: Study
Jul 24, 2014  
Paracetamol, which has long since been prescribed as a painkiller for severe low back pain, is no better than placebo; findings of a recent study in Australia have shown. The trial that was published on Thursday found that the universally recommended painkiller neither speeds recovery nor reduces the pain. Paracetamol is merely acts as a placebo or dummy pills doing nothing to ease the...
Early Treatment to Cure HIV virus Might not be Effective
Jul 23, 2014  
According to a research study, the virus of AIDS, HIV has the capacity of creating invulnerable strongholds in the host’s body rapidly. This has dashed hopes of early treatment for the condition, which might have been helpful to cure the virus. In one case, a baby was thought to be cured with the new treatment after its birth, however, the virus emerged couple of years later. A...